Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

In-vitro and In-vivo Feasibility Study for a Mobile VV-ECMO and ECCO2R System

Version 1 : Received: 3 December 2021 / Approved: 8 December 2021 / Online: 8 December 2021 (14:16:25 CET)

How to cite: Strudthoff, L.J.; Lüken, H.; Jansen, S.V.; Petran, J.; Schlanstein, P.; Schraven, L.; Schürmann, B.J.; Steuer, N.B.; Wagner, G.; Schmitz-Rode, T.; Steinseifer, U.; Arens, J.; Kopp, R. In-vitro and In-vivo Feasibility Study for a Mobile VV-ECMO and ECCO2R System. Preprints 2021, 2021120128 (doi: 10.20944/preprints202112.0128.v1). Strudthoff, L.J.; Lüken, H.; Jansen, S.V.; Petran, J.; Schlanstein, P.; Schraven, L.; Schürmann, B.J.; Steuer, N.B.; Wagner, G.; Schmitz-Rode, T.; Steinseifer, U.; Arens, J.; Kopp, R. In-vitro and In-vivo Feasibility Study for a Mobile VV-ECMO and ECCO2R System. Preprints 2021, 2021120128 (doi: 10.20944/preprints202112.0128.v1).

Abstract

Extracorporeal membrane oxygenation (ECMO) is an established rescue therapy for patients with chronic respiratory failure waiting for lung transplantation (LTx). The therapy inherent immobilization may result in fatigue, consecutive deteriorated prognosis and even lost eligibility for transplantation. We conducted a feasibility study on a novel system designed for the deployment of a mobile ECMO device, enabling physical exercise of awake patients prior to LTx. The system comprises a novel mobile oxygenator with a directly connected blood pump, a double lumen cannula, gas blender and supply, as well as control, and energy management. In-vitro experiments included tests regarding performance, efficiency, and blood damage. A reduced system was tested in vivo for feasibility using a novel large animal model. Six anesthetized pigs were first positioned in supine position, followed by a 45° angle, simulating an upright position of the patients. We monitored performance and vital parameters. All in-vitro experiments showed good performance for the respective subsystems and the integrated system. The acute invivo trials of 8h duration confirmed the results. The novel mobile ECMO-system enables adequate oxygenation and decarboxylation sufficient for, e.g., physical exercise of designated LTx-recipients. These results are promising and suggest further preclinical studies on safety and efficacy to facilitate translation into clinical application.

Keywords

ECMO; ECLS; ECCO2R; ARDS; respiratory failure, LTx, DIN EN ISO 7199; Extracorporeal membrane oxygenation, acute respiratory distress syndrome, animal model

Subject

ENGINEERING, Biomedical & Chemical Engineering

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.